Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Nausea × Gemcitabine × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 51 Nasopharyngeal Carcinoma 20 Cholangiocarcinoma 19 Biliary Tract Neoplasms 19 Urinary Bladder Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Neoplasm Metastasis 14 Lung Neoplasms 12 Breast Neoplasms 12 Carcinoma, Transitional Cell 11 Lymphoma, Large B-Cell, Diffuse 10 Colorectal Neoplasms 10 Recurrence 9 Non-Muscle Invasive Bladder Neoplasms 9 Sarcoma 8 Neoplasms 6 Hodgkin Disease 6 Ovarian Neoplasms 5 Gallbladder Neoplasms 5 Adenocarcinoma 5 Uterine Cervical Neoplasms 4 Nasopharyngeal Neoplasms 4 Leiomyosarcoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Pancreatic Adenocarcinoma 3 Osteosarcoma 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, B-Cell 3 Lymphoma 3 Locally Advanced Pancreatic Cancer 3

Interventions

Olanzapine 3 Palonosetron 2 Electroacupuncture 2 naldemedine 1 Thalidomide 1 Taxes 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡